• Transactions
  • Careers
  • Contact
  • Client Login
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer

SVB Securities

Helping our clients move healthcare and technology forward

  • Sectors
    • Healthcare
      • Biopharma
      • Digital Health & HealthTech
      • Healthcare Services
      • Medical Technology
      • Tools & Diagnostics
    • Technology
      • Consumer Internet, Commerce Enablement & Marketing Software
      • Digital Infrastructure & Tech-Enabled Services
      • Learning Technology
      • Enterprise Software
      • Industrial Technology
      • Fintech
  • Solutions
    • For Corporates
      • M&A Advisory
      • Capital Markets
      • Leveraged Finance & Structured Finance
    • For Investors
      • Equity Research
      • Institutional Equities
      • Corporate Access
  • Intelligence
    • Perspectives
    • SVB MEDACorp
  • Firm
    • About
    • Careers
    • News
    • Transactions

Important News Update

SVB Securities Continues its Independent Operations Unimpeded by Silicon Valley Bank’s Receivership Proceedings
Learn More

Contact Us

Why Partner With Us

At SVB Securities, we share a singular goal to achieve the highest level of success for our clients. We pride ourselves on being the most focused and passionate investment banking professionals in the business.

Learn more

1,180+

Transactions Completed

since 2009Learn More

$230+

Billion
Raised

since 2009Learn More

~360+

Companies
Covered

as of 2/28/2023Learn More

20K+

Key Opinion Leaders in Healthcare

as of 12/31/2020Learn More

Our Expertise

We provide healthcare and technology-focused companies and investors a broad suite of financial solutions comprising of M&A advisory, equity and debt capital markets, proprietary research, and comprehensive sales and trading capabilities.

Capital Markets

We are a market leader partnering with innovative healthcare and technology companies throughout their financial lifecycle. Learn More

M&A Advisory

We leverage our long-term relationships, highly-regarded sector knowledge and transaction experience to deliver outcomes for our clients. Learn More

Institutional Equities

Delivering unique insights on equity-related products for institutional clients. Learn More

Equity Research

Industry recognized equity research analysts offer a differentiated perspective on the healthcare and technology sub-sectors driving innovation. Learn More

Leveraged/Structured Finance

Corporate clients and financial sponsors require expertise in structuring, underwriting, and syndicating a broad array of debt financing solutions. Learn more

SVB MEDACorp

Exclusive access to Key Opinion Leaders (KOLs) and healthcare professionals is an essential service for our Equity Research and Investment Banking teams and healthcare clients as they evaluate opportunities. Learn More

Recent Transactions

See all transactions

$84 Million

Exclusive Financial Advisor
Capital Raise
March 2023

$275 Million

Joint Bookrunner
Follow-On
March 2023

$108 Million

Joint Bookrunner
Follow-On
March 2023

$195 Million

Joint Bookrunner
Follow-On
March 2023

$300 Million

Joint Bookrunner
Follow-On
March 2023

$200 Million

Joint Bookrunner
Follow-On
February 2023

$125 Million

Joint Bookrunner
Follow-On
February 2023

UNDISCLOSED

Exclusive Financial Advisor
Licensing Agreement with Ferrer for ASN90
February 2023

€130 Million

Lead Placement Agent
Private Placement
February 2023

UNDISCLOSED

Exclusive Financial Advisor
Majority Investment by Providence Equity Partners
Pending

UNDISCLOSED

Financial Advisor
Sale of Utah Health Care Sites to Centura Health
Pending

UNDISCLOSED

Financial Advisor
Acquisition of Acsel Health
February 2023

Recent News

View All
SVB Securities Serves as Exclusive Financial Advisor for Wellvana’s $84 Million Capital Raise
Learn More
SVB Securities Serves as Joint Bookrunner for 89bio’s (Nasdaq:ETNB) Upsized $275 Million Follow-On Offering
Learn More
SVB Securities Sets Record Straight on the Current and Previous Role of Chief Administrative Officer Joseph Gentile
Learn More
SVB Securities Serves as Joint Bookrunner for Stagwell’s (NASDAQ: STGW) $108 Million Follow-On Offering
Learn More
SVB Securities Continues its Independent Operations Unimpeded by Silicon Valley Bank’s Receivership Proceedings
Learn More
SVB Securities Serves as Joint Bookrunner for Clearwater Analytics’ (NYSE: CWAN) $195 Million Follow-On Offering
Learn More
SVB Securities Serves as Joint Bookrunner for Revolution Medicines’ (Nasdaq: RVMD) $300 Million Follow-On Offering
Learn More
SVB Securities Serves as Joint Bookrunner for 2seventy bio’s (Nasdaq: TSVT) Upsized $125 Million Follow-On Offering
Learn More

Featured Intelligence

View additional intelligence
Articles

2022: A terrible, horrible, no good, very bad year (for Digital Health)

March 2023
Podcasts

Kindbody Founder and Executive Chairman Gina Bartasi – Episode 5

January 2023
Featured Research

RETA / If Approved, What Could Omav’s Label Look Like? Several Scenarios Possible / Market Perform

February 2023

Partner with Us

to achieve your strategic, capital markets, and investment objectives.

Contact Us

Footer

Sectors

  • Healthcare
  • Technology

Solutions

  • For Corporates
  • For Investors
  • Transactions
  • Advisory

Intelligence

  • Perspectives
  • Research
  • SVB MedaCorp

Firm

  • About
  • Careers
  • News

Contact

  • General
  • Investors
  • Press

Stay ahead of what’s next. Sign Up Now!

Subscribe to receive our thought leadership and marketing updates.

Member  FINRA/SIPC

  • Terms of Use
  • Privacy
  • Cookies
  • Corporate Governance
  • Notice to California Residents
  • Important Disclosures
  • Linkedin
  • Mail

Contact Us

Thank you for visiting SVBSecurities.com. If you would like more information, please submit an inquiry below.

"*" indicates required fields

Name*